Routine practices in use of onasemnogene abeparvovec (OA) in older patients with spinal muscular atrophy (SMA): Early findings from RESTORE Servais, L., De Vivo, D., Kirschner, J., Mercuri, E., Muntoni, F., Tizzano, E., Roy, S., Saito, K., Menier, M., LaMarca, N., Anderson, F., Dabbous, O., Finkel, R. PERGAMON-ELSEVIER SCIENCE LTD. 2021: S138

View details for DOI 10.1016/j.nmd.2021.07.314

View details for Web of Science ID 000697873700299